Artelo Biosciences, Inc. logo

ARTLArtelo Biosciences, Inc.

ARTL Stock Price, Valuation & Chart | Artelo Biosciences, Inc.

Compare

ARTL Historical price chart

ARTL Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization2.53M
PE Ratio-0.32
EPS-20.24
Trading Volume43.08K
Today's High/Low6.71/5.99
Dividend Yield0.00
52 Week High/Low243.0/4.68
Shares Outstanding387.28K
ARTL Financial Statement
ARTL Analyst ratings
ARTL Analysis & performance metrics

ARTL Company profile

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product…

ARTL Management team

Management
Steven D. Reich M.D.
Chief Medical Officer
Jason H. Baybutt
Senior Vice President of Finance
Andrew Yates Ph.D.
Senior Vice President & Chief Scientific Officer
Gregory D. Gorgas M.B.A.CEO
President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary & Director
Total 4 executives

ARTL Frequently asked questions

What is Artelo Biosciences, Inc. (ARTL) Stock Price?

Current stock price of Artelo Biosciences, Inc. (ARTL) stock is $6.520. The stock price is +5.93% higher in the session. The intraday range can be seen from this page. Volume of Artelo Biosciences, Inc. (ARTL) stock is 43.08K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Artelo Biosciences, Inc. (ARTL) stock price going up or down today?

The stock price of Artelo Biosciences, Inc. (ARTL) can change with earnings, company news, and overall market sentiment. Artelo Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Artelo Biosciences, Inc. stock expensive at its current price?

Whether Artelo Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ARTL on this page is -0.32. EPS on this page is -20.24. Compare those figures with peers and growth expectations before deciding if the current Artelo Biosciences, Inc. price is justified.

How has the stock price of Artelo Biosciences, Inc. (ARTL) performed historically?

Historical performance for Artelo Biosciences, Inc. (ARTL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ARTL reacted to past earnings and market events.

Should I buy Artelo Biosciences, Inc. (ARTL) stock, at this price?

Buying Artelo Biosciences, Inc. (ARTL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.